New search    Hide text from Guidelines

This group comprises antidepressants, psychostimulants, nootropics, anti-dementia drugs and combinations with psycholeptics.
Antiobesity preparations are classified in A08 - Antiobesity preparations, excl. diet products.

Some drugs used in the treatment of narcolepsy are classified here.
Nootropics are classified in N06BX.
Clonidine and guanfacine also used in ADHD are classified in C02AC.

N06BA Centrally acting sympathomimetics

Amfetamine is classified in this group, see comment under A08AA - Centrally acting antiobesity products.
Combinations of amfetamine and dexamfetamine are classified in N06BA01.

N06BC Xanthine derivatives

Caffeine in combination with respiratory stimulants is classified in R07AB.

N06BX Other psychostimulants and nootropics

This group comprises substances regarded as nootropics. Psychostimulants, which cannot be classified in the preceding groups, are also classified here.
Cyprodenate (deanol cyclohexylpropionate) is classified in N06BX04.